CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.

Turunen AnttiAnu PartanenJaakko ValtolaAntti RopponenTimo SiitonenOuti KuittinenHanne KuitunenMervi PutkonenMarja SankeloLeena KeskinenEeva-Riitta SavolainenMarja PyöräläTaru KuittinenRaija SilvennoinenKarri PenttiläAnu SikiöKaija VasalaPentti MäntymaaJukka PelkonenVille VarmavuoEsa Jantunen

Published in: Transfusion (2020)

Non-Hodgkin's lymphoma and MM patients differ in terms of mobilization of CD34+ cells, graft cellular composition, and posttransplant recovery. Thus, the optimal graft characteristics may also be different.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
stem cells
diffuse large b cell lymphoma
oxidative stress
signaling pathway